4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-053595
Chief Financial Officer sold 3,000 shares at $4.68 ($14,040)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jeanmonod Patrik Chief Financial Officer | 2023-10-24 | Sale 10b5-1 | −3,000 | $4.68 | $14,040 | 96,084 | D |
| Open-market sales · 3,000 sh · avg $4.68 · $14,040 | |||||||
Loading xslF345X05/doc4.xml…